Aurobindo Pharma rises 2% on USFDA nod

Shares of Aurobindo Pharma rose as much as 2.18% in early morning trade after the company announced it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ertapenem Injection 1 g/vial.

For more information and best STOCK TIPS Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research